MabCure, Inc. (MBCI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 9, 2025

MabCure Company Description

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers.

The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan.

MabCure Inc. was founded in 2006 and is based in White Plains, New York.

MabCure, Inc.
Country United States
Founded 2006
Industry Solar
Sector Technology
Employees 3
CEO Jehu Thomas Hand

Contact Details

Address:
21 Sparrow Circle
White Plains, Nevada 10605
United States
Phone 845 591 3144

Stock Details

Ticker Symbol MBCI
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number US5540941029
SIC Code 2836

Key Executives

Name Position
Jehu Thomas Degerold Hand Chief Executive and Financial Officer and Director